Tradestie Institutional Equity Comparison Engine
BANX vs ACAD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BANX Overall Edge
BANX Captures Institutional Edge (4โ0 Pillars ยท 4โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ArrowMark Financial Corp. Common Stock (BANX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BANX trades at 14.6x Forward P/E with 75.4% operating margin (-0.2% YoY revenue) versus ACAD at 15.8x Forward P/E and 10.2% operating margin (+22.8% YoY). In options structure, BANX sits in UNCLASSIFIED (14th %ile IV; Dealer Gamma Walls on Pro) against ACAD sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BANX
BANX 14.6x vs ACAD 15.8x Fwd P/E
Growth & Margin Winner
BANX
Op Margin 75.4% vs 10.2% ยท YoY -0.2% vs +22.8%
Momentum & Technical Winner
BANX
1Y -11.2% vs -25.9% ยท 52W Pos 8% vs 8%
Options & Structure Winner
BANX
UNCLASSIFIED (14th %ile IV) vs BREAKDOWN (6th %ile IV)
BANX
NASDAQ
ArrowMark Financial Corp. Common Stock
Institutional Equity
$18.79
-0.74% 1D
Market Cap
$183.4M
1M Return
-6.1%
1Y Return
-11.16%
Forward P/E
14.6x
Unified AI Score
39.5 / 100
SELL
Tech 28.0
Fund 46.0
Flow 50.0
Mom 60.0
ACAD
NASDAQ
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$17.11
-2.73% 1D
Market Cap
$3.0B
1M Return
-15.76%
1Y Return
-25.93%
Forward P/E
15.8x
Unified AI Score
44.8 / 100
HOLD
Tech 38.0
Fund 54.0
Flow 67.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BANX -11.16%
ACAD -25.93%
Spread: +14.77 pp (BANX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BANX TTM Op. Margin: 75.4%
ACAD TTM Op. Margin: 10.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BANX vs ACAD. Trailing 12-month operating profitability (BANX 75.4% vs ACAD 10.2%) and valuation multiples (BANX 14.6x vs ACAD 15.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BANX | ACAD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $183.4M | $3.0B | Larger Scale | ACAD |
| Trailing P/E Ratio Valuation | 17.7x | 8.3x | Lower Multiple | ACAD |
| Forward P/E Ratio Valuation | 14.6x | 15.8x | Lower Multiple | BANX |
| Revenue Growth (YoY) Growth | -0.2% | +22.8% | Higher Growth | ACAD |
| Operating Margin (TTM) Profitability | 75.4% | 10.2% | Higher Margin | BANX |
| Net Profit Margin Profitability | 50.8% | 30.1% | Higher Margin | BANX |
| Return on Equity (ROE) Capital Efficiency | 7.4% | 31.4% | Higher ROE | ACAD |
| 52-Week Range Position Momentum | 8% ($18โ$22) | 8% ($16โ$31) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.19ฮฒ ยท 12% Vol | 0.15ฮฒ ยท 90% Vol | Lower Realized Risk | BANX |
| Unified Institutional Score Composite Signal | 39.5 / 100 (SELL) | 44.8 / 100 (HOLD) | Higher Composite | ACAD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BANX vs ACAD Buy Guide
BANX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
14th %ile
IV Regime
Compressed (<25th %ile)
ACAD
BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BANX nor ACAD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.